Replimune Group, Inc.
REPL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001737953
In the last 90 days, Replimune Group, Inc. insiders filed 0 open-market purchases and 5 sales; 199 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Replimune Group, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 141
- +1 vs. Q1 2023
- Shares held
- 54.6M
- +788.1K (+1.5%) vs. Q1 2023
- Total value
- $1.27B
- +$318.3M (+33.5%) vs. Q1 2023
- New holders
- 20
- 45 more added
- Sold out
- 19
- 59 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REPL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 199 | $1.06B |
| Q1 2026 | 180 | $619.2M |
| Q4 2025 | 165 | $775.2M |
| Q3 2025 | 163 | $347.5M |
| Q2 2025 | 175 | $752.1M |
| Q1 2025 | 167 | $799.3M |
| Q4 2024 | 157 | $943.2M |
| Q3 2024 | 144 | $766.7M |
| Q2 2024 | 149 | $638.1M |
| Q1 2024 | 150 | $547.8M |
| Q4 2023 | 140 | $556.8M |
| Q3 2023 | 127 | $970.9M |
| Q2 2023 | 141 | $1.27B |
| Q1 2023 | 140 | $949.0M |
| Q4 2022 | 135 | $1.31B |
| Q3 2022 | 106 | $703.9M |
| Q2 2022 | 102 | $700.2M |
| Q1 2022 | 107 | $665.0M |
| Q4 2021 | 99 | $1.05B |
| Q3 2021 | 101 | $1.05B |
| Q2 2021 | 110 | $1.34B |
| Q1 2021 | 108 | $1.06B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Replimune Group, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ameriprise Financial Inc | 187,627 | $4.36M | 0.00% | −19,852−9.6% | Reduced |
| Nuveen Asset Management, LLC | 194,064 | $4.51M | 0.00% | +3,770+2.0% | Added |
| Wellington Management Group LLP | 208,644 | $4.84M | 0.00% | +63,498+43.7% | Added |
| Sectoral Asset Management Inc | 238,541 | $5.54M | 0.92% | −23,659−9.0% | Reduced |
| Ensign Peak Advisors, Inc | 270,007 | $6.27M | 0.01% | 00.0% | Unchanged |
| Woodline Partners LP | 275,001 | $6.39M | 0.08% | −36,849−11.8% | Reduced |
| Two Sigma Advisers, LP | 279,000 | $6.48M | 0.02% | +52,900+23.4% | Added |
| Charles Schwab Investment Management Inc | 284,946 | $6.62M | 0.00% | −11,707−3.9% | Reduced |
| JPMorgan Chase & Co | 302,919 | $7.03M | 0.00% | +139,709+85.6% | Added |
| Schroder Investment Management Group | 337,662 | $7.84M | 0.01% | −87,193−20.5% | Reduced |
| Sofinnova Investments, Inc. | 348,889 | $8.10M | 0.53% | +348,889 | New |
| Frazier Life Sciences Management, L.P. | 386,762 | $8.98M | 0.54% | −300,000−43.7% | Reduced |
| Millennium Management LLC | 403,873 | $9.38M | 0.01% | −184,088−31.3% | Reduced |
| Northern Trust Corp | 411,842 | $9.56M | 0.00% | −33,911−7.6% | Reduced |
| Amundi | 452,047 | $9.91M | 0.01% | +50,032+12.4% | Added |
| Integral Health Asset Management, LLC | 445,000 | $10.3M | 1.36% | +50,000+12.7% | Added |
| Braidwell LP | 487,520 | $11.3M | 0.37% | +413,855+561.8% | Added |
| Artal Group S.A. | 500,000 | $11.6M | 0.37% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 612,193 | $14.2M | 0.10% | −50,729−7.7% | Reduced |
| Goldman Sachs Group Inc | 612,773 | $14.2M | 0.00% | −31,424−4.9% | Reduced |
| Morgan Stanley | 653,565 | $15.2M | 0.00% | −195,884−23.1% | Reduced |
| T. Rowe Price Investment Management, Inc. | 727,610 | $16.9M | 0.01% | −502,531−40.9% | Reduced |
| Geode Capital Management, LLC | 800,828 | $18.6M | 0.00% | −26,416−3.2% | Reduced |
| Emerald Mutual Fund Advisers Trust | 900,952 | $20.9M | 1.13% | +97,504+12.1% | Added |
| Lord, Abbett & Co. LLC | 1,038,506 | $24.1M | 0.08% | +1,038,506 | New |
| Emerald Advisers, LLC | 1,086,287 | $25.2M | 1.10% | +123,246+12.8% | Added |
| Citadel Advisors LLC | 1,136,118 | $26.4M | 0.03% | +21,206+1.9% | Added |
| Loomis Sayles & Co L P | 1,187,227 | $27.6M | 0.04% | +228,561+23.8% | Added |
| Marshall Wace, LLP | 1,233,224 | $28.6M | 0.06% | +586,336+90.6% | Added |
| Dimensional Fund Advisors LP | 1,284,449 | $29.8M | 0.01% | +207,966+19.3% | Added |
| FMR LLC | 1,544,568 | $35.9M | 0.00% | +391,114+33.9% | Added |
| Camber Capital Management LP | 1,550,000 | $36.0M | 1.17% | +300,000+24.0% | Added |
| State Street Corp | 2,088,981 | $48.5M | 0.00% | −815,373−28.1% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $48.7M | 6.06% | 00.0% | Unchanged |
| BVF Inc | 2,143,036 | $49.8M | 1.39% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,353,899 | $54.7M | 0.00% | −28,492−1.2% | Reduced |
| Omega Fund Management, LLC | 3,001,319 | $69.7M | 39.05% | −48,868−1.6% | Reduced |
| BlackRock Inc. | 3,494,046 | $81.1M | 0.00% | −128,058−3.5% | Reduced |
| Redmile Group, LLC | 4,420,533 | $102.6M | 3.94% | +608,545+16.0% | Added |
| Baker Bros. Advisors LP | 4,578,280 | $106.3M | 0.62% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 5,733,012 | $133.1M | 0.02% | +237,396+4.3% | Added |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −691,212−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −141,700−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −99,182−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −39,500−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −38,909−100.0% | Sold out |
| Hennion & Walsh Asset Management, Inc. | 0 | $0 | 0.00% | −34,131−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −31,800−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −28,282−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −26,161−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,557−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −23,642−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −17,231−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −12,305−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −12,003−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −10,832−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −4,300−100.0% | Sold out |
| Robeco Institutional Asset Management B.V. | 0 | $0 | 0.00% | −3,552−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −230−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −23−100.0% | Sold out |